SPXC vs. XBI
Compare and contrast key facts about SPX Corporation (SPXC) and SPDR S&P Biotech ETF (XBI).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SPXC or XBI.
Key characteristics
| SPXC | XBI | |
|---|---|---|
| YTD Return | 66.73% | 16.11% |
| 1Y Return | 101.09% | 54.88% |
| 3Y Return (Ann) | 37.09% | -6.45% |
| 5Y Return (Ann) | 29.21% | 4.31% |
| 10Y Return (Ann) | 22.19% | 6.57% |
| Sharpe Ratio | 3.07 | 2.12 |
| Sortino Ratio | 3.40 | 2.89 |
| Omega Ratio | 1.48 | 1.34 |
| Calmar Ratio | 6.20 | 0.91 |
| Martin Ratio | 19.86 | 7.24 |
| Ulcer Index | 5.14% | 7.70% |
| Daily Std Dev | 33.33% | 26.31% |
| Max Drawdown | -81.12% | -63.89% |
| Current Drawdown | -1.94% | -40.39% |
Correlation
The correlation between SPXC and XBI is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
SPXC vs. XBI - Performance Comparison
In the year-to-date period, SPXC achieves a 66.73% return, which is significantly higher than XBI's 16.11% return. Over the past 10 years, SPXC has outperformed XBI with an annualized return of 22.19%, while XBI has yielded a comparatively lower 6.57% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SPXC vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for SPX Corporation (SPXC) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SPXC vs. XBI - Dividend Comparison
SPXC has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.14%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SPXC SPX Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.02% | 1.75% | 1.00% |
XBI SPDR S&P Biotech ETF | 0.14% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% | 0.17% |
Drawdowns
SPXC vs. XBI - Drawdown Comparison
The maximum SPXC drawdown since its inception was -81.12%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for SPXC and XBI. For additional features, visit the drawdowns tool.
Volatility
SPXC vs. XBI - Volatility Comparison
SPX Corporation (SPXC) has a higher volatility of 14.59% compared to SPDR S&P Biotech ETF (XBI) at 4.96%. This indicates that SPXC's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.